Robinhood shares gain on Q2 beat, as user and crypto growth accelerate
Investing.com - Alpine Immune Sciences reported on Monday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Alpine Immune Sciences announced earnings per share of $-0.420 on revenue of $8.37M. Analysts polled by Investing.com EPS of $-0.090 on revenue of $18.69M.
Alpine Immune Sciences 's are down 36% and is trading at $5.740 , still down 60.14% from its 52 week high of $14.40 set on Friday, December 31, 2021.
Alpine Immune Sciences follows other major Healthcare sector earnings this month
Alpine Immune Sciences's report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar